Accelerant Holdings (ARX) Stock Price & Analysis

Accelerant Holdings (ARX) closed at USD 19.76 on Thursday, October 22, 2026, up 0.05% on the day. The US market is currently closed (pre-market); this is not a live price.

The prior close was USD 19.75; the Oct 22, 2026 session ranged USD 19.73–19.85 on volume of 1,481,972 shares. Market capitalization is $4.29B, with a 52-week range of USD 9.18–19.9 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 08:39 UTC.

Also available as compact Markdown for AI agents: nexqual.com/ARX.md

Key facts (ARX)

• Last four reported quarters (through Jun 30, 2026): revenue $1.15B, net income -$1.28B (-112.1% margin) (SEC filings).
• 1 of 80 tracked superinvestors hold ARX (13F, Q2 2026): 0 new, 0 added, 0 reduced, 1 unchanged.
• Insider open-market sales, last ~7 months: 17 Form 4 filings, $20.9M; 1 not under a Rule 10b5-1 plan ($11K); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
• Analysts: Hold (mean 3.33 on a 1–5 scale) (6 analysts), mean target USD 20.25 (range 20.25–20.25).
• Total return with dividends: 1Y +59.4% vs S&P 500 +14.9%; 5Y -33.7% vs S&P 500 +80.3%.
• Next earnings: 2026-11-11, EPS estimate USD 0.2, revenue estimate $265M.

Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (ARX)

Fiscal years end Dec. EPS is split-adjusted.

Valuation (price ÷ last four quarters, through Jun 30, 2026) (ARX)

P/S 3.7x · EV/Sales 2.5x · P/B 6.0x · Earnings yield -29.93% · Net cash $1.45B · EV $2.84B

Superinvestors (SEC 13F-HR, Q2 2026) (ARX)

1 of 80 tracked investors hold ARX. Each row is the investor's latest 13F; change is vs their prior-quarter share count.

Insider sales (SEC Form 4, open-market, last ~7 months) (ARX)

16 of 17 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.

% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).

Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.

Analysts (ARX)

Consensus Hold (mean 3.33 on a 1–5 scale), 6 analysts; mean target USD 20.25 (low 20.25, high 20.25).

Rating changes, last 120 days:

Total return (dividends reinvested) (ARX)

ARX revenue by business segment (quarter ended Sep 30, 2025)

ARX revenue by region (quarter ended Jun 30, 2026)

As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).

ARX suppliers, customers and competitors (named in its 10-K)

Quoted from the company's 10-K filed Mar 18, 2026.

ARX company outlook (results filed Aug 13, 2026)

• “In addition, Accelerant will not provide guidance for the third quarter of 2026 or the full year of 2026 as a result of the pending transaction.”

Quoted word-for-word from the SEC 8-K results press release.

ARX analyst estimates and revisions

ARX options: expected move

Options price a move of about ±3.5% (±$0.70) by Nov 20, 2026, which includes earnings on Nov 11, 2026. Over the last 6 reports the stock moved ±18.1% on average.

30-day implied volatility 8.6% vs 3.8% realized over the last 30 trading days. Put/call ratio (volume) 5. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.

Key Statistics (as of October 23, 2026 at 08:39 UTC)

Technical Analysis (ARX)

Nexqual's technical model rates ARX "STRONG BUY" based on 5 bullish and 0 bearish signals across 127 daily candles, as of October 23, 2026 at 08:39 UTC.

Analyst Ratings (ARX)

Wall Street analysts rate ARX "Hold" based on 6 analysts, with a mean price target of USD 20.25 (range USD 20.25–20.25), per Nexqual as of October 23, 2026 at 08:39 UTC.

Earnings (ARX)

Recent Earnings History

Source: Nexqual, October 23, 2026 at 08:39 UTC.

Financials & Fundamentals (ARX)

Source: Nexqual, October 23, 2026 at 08:39 UTC.

Financial Health Score (ARX)

Nexqual rates Accelerant Holdings's overall financial health "Solid" across five dimensions, as of October 23, 2026 at 08:39 UTC.

Ownership (ARX)

Source: Nexqual, October 23, 2026 at 08:39 UTC.

Leadership (ARX)

Accelerant Holdings is led by Jeffrey Lee Radke, Co-Founder, CEO & Director, per Nexqual as of October 23, 2026 at 08:39 UTC.

Major Backers & Investors (ARX)

Notable institutional backers of Accelerant Holdings include SECURITY BENEFIT LIFE INSURANCE CO, FMR, LLC, Fidelity, according to Nexqual as of October 23, 2026 at 08:39 UTC.

Active Investors

Index Funds (Passive)

Source: Nexqual, October 23, 2026 at 08:39 UTC.

From Accelerant Holdings's Latest SEC 10-K Filing (filed 2026-03-18)

Key Strengths & Strategy (as disclosed to the SEC)

• We collect Member exposure data from both structured and unstructured environments and combine it into a single dataset that, as of December 31, 2025, consisted of over 58 thousand unique attributes across more than 134 million rows of proprietary data from over 1,800 unique data mappings.
• As of December 31, 2025, our dataset consisted of over 58 thousand unique attributes across more than 134 million rows of proprietary data from over 1,800 unique data mappings.
• By harnessing our proprietary technology, access to data, and industry experience, we believe we have created the future marketplace of the specialty insurance industry.
• Our proprietary ingestion tools allow us to capture insurance data from disparate and complex data environments.

Partnerships

• We take a disciplined approach to managing and monitoring risk in collaboration with Members that combines our data insights with advice from insurance industry veterans.
• Whether they participate on the Risk Exchange directly or through reinsurance, we have partnered with a broad group of high-quality Risk Capital Partners who are attracted to the Risk Exchange by the portfolio's consistent and profitable underwriting performance.

Legal & Regulatory Risks (Item 1A, quoted)

• Our businesses are subject to significant governmental regulation, changes in which could reduce our profitability, limit our growth, or increase competition.
• Our insurance and reinsurance company subsidiaries and agency subsidiaries are subject to extensive regulation, which may adversely affect our ability to operate and achieve our business objectives. In addition, if we fail to comply with these regulations, we may be subject to penalties, including fines and suspensions, which may adversely affect our results of operations and financial condition.
• We cannot predict the impact that any new laws, rules, or regulations may have on our business, results of operations, financial condition, and prospects.
• We are subject to a number of, and may in the future be subject to, E&O claims as well as other contingencies and legal proceedings which, if resolved unfavorably to us, could have an adverse effect on our results of operations.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 08:39 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt